TCOYD SPONSOR HIGHLIGHT
Dexcom, Inc. empowers people to take control of diabetes through innovative continuous glucose monitoring (CGM) systems. Headquartered in San Diego, California, Dexcom has emerged as a leader of diabetes care technology. By listening to the needs of users, caregivers, and providers, Dexcom simplifies and improves diabetes management around the world.
EVERYTHING YOU NEED TO KNOW ABOUT CGMS
FEATURES AND BENEFITS
USING CGMS TO MANAGE YOUR DIABETES: PRESENTED BY TCOYD FACULTY
MORE ABOUT DEXCOM
*If your glucose alerts and readings from the G6 do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.
* Fingersticks required for diabetes treatment decisions if symptoms or expectations do not match readings.
Smart devices sold separately.
† For a list of compatible devices, visit www.dexcom.com/compatibility.
‡ Separate Follow App required.
§ The Dexcom G6 Sensor and Transmitter are water-resistant and may be submerged under eight feet of water for up to 24 hours without failure when properly installed.
BRIEF SAFETY STATEMENT
Failure to use the Dexcom G6 Continuous Glucose Monitoring System (G6) and its components according to the instructions for use provided with your device and available at www.dexcom.com/safety-information and to properly consider all indications, contraindications, warnings, precautions, and cautions in those instructions for use may result in you missing a severe hypoglycemia (low blood glucose) or hyperglycemia (high blood glucose) occurrence and/or making a treatment decision that may result in injury. If your glucose alerts and readings from the G6 do not match symptoms or expectations or you’re taking over the recommended maximum dosage amount of 1000mg of acetaminophen every 6 hours, use a blood glucose meter to make diabetes treatment decisions. Seek medical advice and attention when appropriate, including for any medical emergency.